RTW Investments’s Tandem Diabetes Care TNDM Stock Holding History

RTW Investments’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-322,000	Closed	-$15.4M	–	79
2022 Q3	$15.4M	Sell	322,000 -600,630	-65%	-$32.9M	0.36%	43
2022 Q2	$54.6M	Sell	922,630 -82,306	-8%	-$6.76M	1.41%	26
2022 Q1	$117M	Sell	1,004,936 -155,798	-13%	-$18.2M	2.42%	12
2021 Q4	$175M	Hold	1,160,734	–	–	2.55%	11
2021 Q3	$139M	Buy	1,160,734 +13,326	+1%	+$1.47M	2.09%	14
2021 Q2	$112M	Buy	1,147,408 +8,178	+0.7%	+$729K	1.69%	21
2021 Q1	$101M	Buy	1,139,230 +478,248	+72%	+$44.4M	1.57%	21
2020 Q4	$63.2M	Buy	660,982 +57,501	+10%	+$5.93M	1.06%	29
2020 Q3	$68.5M	Buy	603,481 +4,558	+0.8%	+$479K	1.65%	19
2020 Q2	$59.2M	Buy	598,923 +155,198	+35%	+$12.4M	1.67%	22
2020 Q1	$28.6M	Buy	+443,725	New	+$31.1M	1.23%	30

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RTW Investments's TNDM Position: Q4 2022 in Review

RTW Investments sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 322,000 shares — an estimated $15.4M sold.

RTW Investments first reported a position in TNDM in Q1 2020 and held it in 11 quarters. The position peaked at $175M in Q4 2021. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

RTW Investments reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
RTW Investments sold 322,000 Tandem Diabetes Care shares in Q4 2022, an estimated $15.4M.
RTW Investments first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 11 quarters.
RTW Investments's Tandem Diabetes Care position peaked at $175M in Q4 2021.
295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on RTW Investments's 13F filing for Q4 2022, filed 14 Feb 2023.